HENDERSON, Nev. – May 10, 2023 – (ACCESSWIRE) – Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing, today announced financial results for the first quarter of 2023. “We are pleased to report a solid Q1 2023 with revenue growth of 23%… Read more »
Presentation April 27, 2023 at 2:30 p.m. EDT HENDERSON, Nev. – April 19, 2023 – (Business Wire) – Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, today announced it will present at the Ladenburg Thalmann Technology Expo in New York City… Read more »
HENDERSON, Nev. – April 12, 2023 – (Business Wire) – Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing, will discuss first quarter 2023 earnings at 5:00 p.m. Eastern time on Wednesday, May 10, 2023. Participant details are as follows: U.S. dial-in:… Read more »
Our article, “Identifying Copay Accumulator Impact: Winning the Race for Patient Access” by Matt Turner, President of Patient Affordability, is featured in PM360, the essential resource for pharma marketers, April Issue. This Expert on Call article is our second article, further exploring the financial impacts of copay accumulators on manufacturers and patients, and how to… Read more »
Our guest post, “Winning the Race for Patient Access: Identifying Copay Accumulator Impact” is featured on Drug Channels, an established site which includes expert insights on pharmaceutical economics and the drug distribution system. This article discusses the financial impacts of copay accumulators on manufacturers and patients, and how to reduce the financial strain and strive… Read more »
Paysign is thrilled to be a gold sponsor at the upcoming Asembia Specialty Pharmacy Summit, taking place April 30-May 04, 2023, at the Wynn Las Vegas. Our Patient Affordability team will be there sharing our adaptable and scalable suite of solutions designed to streamline programs and eliminate unnecessary costs – powering the convergence of fintech… Read more »
Company’s Board Authorizes $5 Million Share Repurchase Program HENDERSON, Nev. – March 21, 2023 – (Business Wire) – Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, today announced financial results for the fourth quarter and full-year 2022. “We closed out 2022… Read more »
HENDERSON, Nev. – March 21, 2023 – (Business Wire) – Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, today announced that its Board of Directors has authorized a new stock repurchase program of up to $5,000,000 of the company’s outstanding common… Read more »
Paysign is excited to be a supporting sponsor at the ACCESS USA hybrid event, Accelerating Access, Partnerships and Collaboration to Deliver Superior Patient Outcomes, in Philadelphia, PA on March 20-23, 2023. Our Patient Affordability team will be there, sharing insights on copay accumulators, the patient journey, drug pricing, and the continuing need for transparency within… Read more »
Henderson, Nev. – February 23, 2023 – (Business Wire) – Paysign Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing, will discuss fourth quarter and full-year 2022 earnings at 5:00 p.m. Eastern time on Tuesday, March 21, 2023. Participant details are as follows:… Read more »
Want to learn more? Let’s talk about how Paysign can help you achieve your goals.